BioCentury
ARTICLE | Clinical News

Ampakine Org 24448: Began Phase II trial

September 24, 2001 7:00 AM UTC

N.V. Organon, Oss, the Netherlands Product: Ampakine Org 24448 Business: Neurological Therapeutic category: Neurotransmission Target: AMPA glutamate receptor Description: Ampakine enhancer of the AMP...